Holen Sie sich die Stockscreener-App
2.34
8.24%
-0.21
Schlusskurs vom Vortag:
$2.55
Offen:
$2.49
24-Stunden-Volumen:
237.65K
Relative Volume:
11.83
Marktkapitalisierung:
$4.05M
Einnahmen:
$17.72M
Nettoeinkommen (Verlust:
$-3.37M
KGV:
-1.1482
EPS:
-2.038
Netto-Cashflow:
$-3.72M
1W Leistung:
-2.50%
1M Leistung:
-17.61%
6M Leistung:
-42.65%
1J Leistung:
-27.55%
1-Tages-Spanne:
$2.31
$2.49
1-Wochen-Bereich:
$2.31
$2.56
52-Wochen-Spanne:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Firmenname
Sonoma Pharmaceuticals Inc
Sektor
Telefon
800-759-9305
Adresse
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
2.34 | 4.05M | 17.72M | -3.37M | -3.72M | -2.038 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten
Sonoma Pharmaceuticals Launches Advanced Burn Relief Hydrogel in Walmart and CVS Stores Nationwide - AD HOC NEWS
CVS Now Stocking Sonoma Pharmaceuticals' HOCl-Based Burn Relief Hydrogel - GuruFocus
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart - Bitget
Sonoma Pharmaceuticals launches burn relief gel at CVS, Walmart - Investing.com
Burn relief gel for minor burns heads to CVS and Walmart nationwide - Stock Titan
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin - Shreveport Times
Pharma News: What is Sonoma Pharmaceuticals Incs revenue forecastQuarterly Risk Review & Real-Time Stock Price Movement Reports - baoquankhu1.vn
SNOA Technical Analysis & Stock Price Forecast - Intellectia AI
Sonoma Pharmaceuticals launches Aquanil AD product line By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals launches Aquanil AD - TipRanks
Sonoma Pharmaceuticals launches Aquanil AD product line - Investing.com
Sonoma Pharmaceuticals (SNOA) Launches New Aquanil AD Product Li - GuruFocus
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquan - PharmiWeb.com
Fierce Biotech Layoff Tracker 2026: Vistagen trims team 20%; Evotec to lay off 800 - Fierce Biotech
Layoff Tracker: Vistagen, Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds - BioSpace
Performance Recap: Can Sonoma Pharmaceuticals Inc expand into new markets2026 Historical Comparison & Accurate Buy Signal Notifications - baoquankhu1.vn
Street Watch: Will Fuel Tech Inc benefit from geopolitical trends2026 Intraday Action & Expert Approved Trade Ideas - baoquankhu1.vn
SNOA SEC FilingsSonoma Pharmaceu 10-K, 10-Q, 8-K Forms - Stock Titan
SILO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Comparing Sonoma Pharmaceuticals (NASDAQ:SNOA) & Dominari (NASDAQ:DOMH) - Defense World
Why Sonoma Pharmaceuticals Inc. stock is popular among millennialsJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - mfd.ru
Can Sonoma Pharmaceuticals Inc. (O8Z) stock surprise with quarterly resultsWeekly Trade Review & AI Forecasted Entry and Exit Points - mfd.ru
Is Sonoma Pharmaceuticals Inc. currently under institutional pressureMarket Performance Recap & Technical Analysis for Trade Confirmation - mfd.ru
SNOA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Valuation Update: What is Sonoma Pharmaceuticals Incs revenue forecast2025 Price Momentum & Accurate Trade Setup Notifications - baoquankhu1.vn
Scar Treatment Market to Reach US$ 49.2 Bn by 2033 Expands Amid Rising Aesthetic Demand and Technological InnovationPersistence Market Research - PR Newswire UK
Moving Averages: Is Anywhere Real Estate Inc stock forming a cup and handle - baoquankhu1.vn
How Sonoma Pharmaceuticals Inc. (O8Z) stock performs during market turbulenceWeekly Stock Analysis & Risk Managed Investment Signals - mfd.ru
Aug Breakouts: Is Sonoma Pharmaceuticals Inc currently under institutional pressureJuly 2025 Action & Growth Oriented Trade Recommendations - baoquankhu1.vn
Will CAMP stock outperform tech sector in 20252025 Macro Impact & Weekly High Return Stock Forecasts - mfd.ru
What are Sonoma Pharmaceuticals Inc.’s earnings expectationsPortfolio Return Report & Low Risk High Reward Ideas - mfd.ru
Is Sonoma Pharmaceuticals Inc. stock affected by interest rate hikesEarnings Growth Report & Expert Curated Trade Setups - mfd.ru
Will Sonoma Pharmaceuticals Inc. stock go up in YEAROptions Play & AI Forecasted Stock Moves - mfd.ru
Published on: 2026-02-12 16:52:50 - mfd.ru
Can Sonoma Pharmaceuticals Inc. scale operations efficiently2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - mfd.ru
Should you avoid Sonoma Pharmaceuticals Inc. stock right nowEarnings Growth Summary & Risk Adjusted Buy/Sell Alerts - mfd.ru
Hypochlorous Acid Market Size, Share | Growth Forecast [2034] - Fortune Business Insights
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results - ACCESS Newswire
US revenue jumps 98% as Sonoma expands hypochlorous acid line - Stock Titan
Can Sonoma Pharmaceuticals Inc. maintain its current growth rateJuly 2025 Weekly Recap & Daily Chart Pattern Signal Reports - mfd.ru
Scar Treatment Market Expected See Incredible Growth - openPR.com
Why Sonoma Pharmaceuticals Inc. stock could be next big winnerWeekly Market Report & Technical Confirmation Alerts - mfd.ru
Treatment Type Analysis - Market.us
Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):